Hormonal regulation of osteoclast function

Trends in Endocrinology and Metabolism

Volumn 9, Issue 1, 1998, Pages 6-12

  Martin, T John ^a   Udagawa, Nobuyuki ^b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

CELL SURVIVAL; HORMONAL REGULATION; HUMAN; IMMUNOREGULATION; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; STROMA CELL;

EID: 0031944247     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(98)00005-8     Document Type: Article

References (73)

1. Akatsu T, Takahashi N, Udagawa Net al. Parathyroid hormone (PTH)-related protein is a potent stimulator of osteoclast-like multinucleated cell formation to the same extent as PTH in mouse marrow cultures. Endocrinology. 125:1989;20-27.
2. Akatsu T, Takahashi N, Udagawa Net al. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res. 6:1991;183-190.
3. Akatsu T, Tamura T, Takahashi Net al. Preparation and characterization of a mouse osteoclast-like multinucleated cell population. J Bone Miner Res. 7:1992;1297-1306.
4. Anderson DM, Maraskovsky E, Billingsley WLet al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:1997;175-179.
5. Baron R Molecular mechanisms of bone resorption by the osteoclast. Anat Rec. 224:1989;317-324.
6. Binstock ML, Mundy GR Effect of calcitonin and glucocorticoids in combination on the hypercalcemia of malignancy. Ann Intern Med. 93:1980;269-272.
7. Boyde A, Ali NN, Jones SJ Resorption of dentine by isolated osteoclasts in vitro. Br Dent. J 156:1984;216-220.
8. Chambers TJ, Magnus CJ Calcitonin alters behaviour of isolated osteoclasts. J Pathol. 136:1982;27-39.
9. Chambers TJ, Athanasou NA, Fuller K Effect of parathyroid hormone and calcitonin on the cytoplasmic spreading of isolated osteoclasts. J Endocrinol. 102:1984;281-286.
10. Chambers TJ, Revell PA, Fuller K, Athanasou NA Resorption of bone by isolated rabbit osteoclasts. J Cell Sci. 66:1984;383-399.
11. Dempster DW, Moonga BS, Stein LS, Horbert WR, Antakly T Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis. J Endocrinol. 154:1997;397-406.
12. Evely RS, Bonomo A, Schneider H-G, Moseley JM, Gallagher J, Martin TJ Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts. J Bone Miner Res. 6:1991;85-93.
13. Fuller K, Owens JM, Jagger CJ, Wilson A, Moss R, Chambers TJ Macrophage colony-stimulating factor stimulates survival and chemotactic behaviour in isolated osteoclasts. J Exp Med. 178:1993;1733-1744.
14. Gallwitz WE, Mundy GR, Lee CHet al. 5-Lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices. J Biol Chem. 268:1993;10087-10094.
15. Girasole G, Jilka RL, Passeri Get al. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest. 89:1992;883-891.
16. Girasole G, Passeri G, Jilka RL, Manolagas SC Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest. 93:1994;1516-1524.
17. Grey A, Mitnick M, Manolagas SCet al. Interleukin-6 mediates PTH-induced bone resorption in vivo [abst]. J Bone Miner Res. 12(Suppl 1):1997;S112.
18. Hattersley G, Owens J, Flanagan AM, Chambers TJ Macrophage colony-stimulating factor (M-CSF) is essential for osteoclast formation in vitro. Biochem Biophys Res Commun. 177:1991;526-531.
19. Hofstetter W, Wetterwald A, Cecchini MC, Felix R, Fleisch H, Mueller C Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts. Proc Natl Acad Sci USA. 89:1992;9637-9641.
20. Horwood NJ, Udagawa N, Elliott Jet al. Interleukin-18 inhibits osteoclast formation via T-cell production of GM-CSF [abst]. J Bone Miner Res. 12(Suppl 1):1997;183.
21. Jilka RL, Hangoc G, Girasole Get al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 257:1992;88-91.
22. Jimi E, Shuto T, Koga T Macrophage colony-stimulating factor and interleukin-1α maintain the survival of osteoclast-like cells. Endocrinology. 136:1995;808-811.
23. Jimi E, Nakamura I, Amano Het al. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology. 137:1996;2187-2190.
24. Kalu DN Proliferation of tartrate-resistant acid phosphatase positive multinucleate cells in ovariectomized animals. Proc Soc Exp Biol Med. 195:1990;70-74.
25. Kimble RB, Vannice JL, Bloedow DCet al. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest. 93:1994;1959-1967.
26. Kimble RB, Srivastava S, Ross FPet al. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1- and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem. 271:1996;28890-28897.
27. Kimble RB, Bain S, Pacifici RL The functional block of TNF but not IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res. 12:1997;935-941.
28. Kurihara N, Suda T, Miura Yet al. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood. 74:1989;1295-1302.
29. Lee MY, Eyre DR, Osborne WRA Isolation of a murine osteoclast colony-stimulating factor. Proc Natl Acad Sci USA. 88:1991;8500-8504.
30. Liu B, Guo J, Lanske B, Kronenberg HM, Bringhurst FR Expression of the PTH/PTHrP receptor by osteoclast progenitors is not required for PTH-dependent osteoclastogenesis [abst]. J Bone Miner Res. 12(Suppl 1):1997;S272.
31. Lorenzo JA, Raisz LG DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones. J Clin Invest. 72:1983;1924-1929.
32. Martin TJ, Ng KW Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem. 56:1994;357-366.
33. Martin TJ, Findlay DM, Moseley JM, Sexton PM: 1998. Calcitonin. In Avioli L. V., Krane S. M., eds. Metabolic Bone Disease and Clinically Related Disorders, 3rd ed. London, U. K., Academic Press, pp 95-121.
34. Masuzawa T, Miyaura C, Onoe Yet al. Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest. 94:1994;1090-1097.
35. McSheehy PM, Chambers TJ Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology. 118:1986;824-828.
36. McSheehy PM, Chambers TJ Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology. 119:1986;1654-1659.
37. Miyaura C, Onoe Y, Inada Met al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci USA. 94:1997;9360-9365.
38. Pacifici R, Rifas L, McCracken Ret al. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA. 86:1989;2398-2402.
39. Pan G, Ni J, Wei Y-Fet al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science. 277:1997;815-818.
40. 35,000 protein(s) that selectively binds to beta-adrenergic receptor mRNAs. J Biol Chem. 267:1992;24103-24108.
41. Rakopoulos M, Ikegame M, Findlay DM, Martin TJ, Moseley JM Short treatment of osteoclasts in bone marrow culture with calcitonin causes prolonged suppression of calcitonin receptor mRNA. Bone. 17:1995;447-453.
42. Rodan GA, Martin TJ Role of osteoblasts in hormonal control of bone resorption - a hypothesis. Calif Tissue Int. 33:1981;349-351.
43. Romas E, Udagawa N, Zhou Het al. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med. 183:1996;2581-2591.
44. Sarma U, Flanagan AM Macrophage colony-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures. Blood. 88:1996;2531-2540.
45. Sheridan JP, Marsters SA, Pitti RMet al. Control of TRAIL-induced apoptosis by a family of signalling and decoy receptors. Science. 277:1997;818-821.
46. Simonet WS, Lacey DL, Dunstan CRet al. Osteoprotegerin - a novel secreted protein involved in the regulation of bone density. Cell. 89:1997;309-319.
47. Suda T, Takahashi N, Martin TJ Modulation of osteoclast differentiation. Endocr Rev. 13:1992;66-88.
48. Suda T, Takahashi N, Martin TJ: 1995. Modulation of osteoclast differentiation: update. In Bikle D. D., Negrovilar A., eds. Endocrine Review Monographs Vol. 4. Bethesda, M. D., Endocrine Society, pp 266-270.
49. Suda T, Udagawa N, Takahashi N: 1996. Cells of bone: osteoclast generation. In Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. London, UK., Academic Press, pp 97-102.
50. Suzuki H, Nakamura I, Takahashi Net al. Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts. Endocrinology. 137:1996;4685-4690.
51. Takahashi N, Akatsu T, Udagawa Net al. Osteoblastic cells are involved in osteoclast formation. Endocrinology. 123:1988;2600-2602.
52. Takahashi N, Yamana H, Yoshiki Set al. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology. 122:1988;1373-1382.
53. Takeda S, Yoshizawa T, Fukumoto Set al. Bone metabolism and in vitro osteoclast formation in VDR knock-out mice [abst]. J Bone Miner Res. 12(Suppl 1):1997;32.
54. Tamura T, Udagawa N, Takahashi Net al. Soluble interleukin-6 triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA. 90:1993;11924-11928.
55. Tanaka S, Takahashi N, Udagawa Net al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest. 91:1993;257-263.
56. Tobias J, Chambers TJ Glucocorticoids impair bone resorptive activity and viability of osteoclasts disaggregated from neonatal rat long bones. Endocrinology. 125:1989;1290-1295.
57. Tsuda E, Goto M, Mochizuki Set al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun. 234:1997;137-142.
58. Udagawa N, Takahashi N, Akatsu Tet al. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 125:1989;1805-1813.
59. Udagawa N, Takahashi N, Akatsu Tet al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA. 87:1990;7260-7264.
60. Udagawa N, Takahashi N, Katagiri Tet al. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med. 182:1995;1461-1468.
61. Udagawa N, Horwood NJ, Elliott Jet al. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med. 185:1997;1005-1012.
62. 2 synthesis [abst]. J Bone Miner Res. 12(Suppl 1):1997;S342.
63. Uy HL, Guise TA, de la Mata Jet al. Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo. Endocrinology. 136:1995;3207-3212.
64. van der Pluijm G, Most W, van der Wee-Pals L, de Groot H, Papapoulos S, Lowik C Two distinct effects of recombinant human tumor necrosis factor-α on osteoclast development and subsequent resorption of mineralized matrix. Endocrinology. 129:1991;1596-1604.
65. Wada S, Martin TJ, Findlay DM Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells. Endocrinology. 136:1995;2611-2621.
66. Wada S, Udagawa N, Nagata N, Martin TJ, Findlay DM Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase A-mediated mechanism. Endocrinology. 137:1996;312-320.
67. Wada S, Udagawa N, Akatsu T, Nagata N, Martin TJ, Findlay DM Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts. Endocrinology. 138:1997;521-529.
68. Wener JA, Gorton SJ, Raisz LG Escape from inhibition or resorption in cultures of fetal bone treated with calcitonin and parathyroid hormone. Endocrinology. 90:1972;752-759.
69. Wong BR, Rho J, Arron Jet al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem. 272:1997;25190-25194.
70. Xu LX, Kukita T, Nakano Yet al. Osteoclasts in normal and adjuvant arthritis bone tissues express the mRNA for both type I and II interleukin-1 receptors. Lab Invest. 75:1996;677-687.
71. Yasuda H, Shima N, Nakagawa N, et al.: 1998. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology (in press).
72. Yasuda H, Shima N, Nakagawa N, et al.: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and identical to TRANCE/RANKL. Proc Natl Acad Sci USA (in press).
73. Zaidi M, Datta HK, Moonga BS, MacIntyre I Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways. J Endocrinol. 126:1990;473-481.